OTC - ACTIVE INGREDIENT SECTION
Active Ingredient
Benzalkonium Chloride 0.1%
Purpose: Antibacterial
Active Ingredient
Benzalkonium Chloride 0.1%
Purpose: Antibacterial
Use
To decrease bacteria on the skin that could cause disease.
Keep out of reach of children.
Warnings
Directions
Inactive Ingredients
water (aqua/eau), glycerin, coceth-7, PPG-1-PEG-9 lauryl glycol ether, carbomer, hydrogenated castor oil, fragrance (parfum).
May Contain
Red 40 (CI 16035), Red 33 (CI 17200), Blue 1 (CI 42090), Yellow 5 (CI 19140).
Avengers Marvel Hand Sanitizer
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58737-162-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4acc-a910-e053-dadaa90a0b85 | 39bbf572-e889-2c74-e054-00144ff8d46c |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58737-162-01 | Avengers Marvel Hand Sanitizer | 59 g in 1 BOTTLE | GEL | 59 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58737-162 | 58737-162-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| COCETH-7 CARBOXYLIC ACID | 35KO064932 | IACT |
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | IACT |
| PEG-40 CASTOR OIL | 4ERD2076EF | IACT |
| PPG-1-PEG-9 LAURYL GLYCOL ETHER | 5R8J43K25L | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 39bc30d5-f93f-696e-e054-00144ff88e88 | 39bbf572-e889-2c74-e054-00144ff8d46c | 2016-08-10 | Warnings | 39bc30d5-f93f-696e-e054-00144ff88e88 39bbf572-e889-2c74-e054-00144ff8d46c |
Adverse event summaries are temporarily unavailable. Other product information remains available.